Monsanto Co. (MON) Shares Sold by Hanson & Doremus Investment Management
Hanson & Doremus Investment Management decreased its stake in Monsanto Co. (NYSE:MON) by 0.7% during the second quarter, Holdings Channel reports. The institutional investor owned 4,736 shares of the company’s stock after selling 35 shares during the period. Hanson & Doremus Investment Management’s holdings in Monsanto were worth $490,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Signaturefd LLC raised its position in Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares in the last quarter. Enterprise Financial Services Corp raised its position in Monsanto by 4.5% in the second quarter. Enterprise Financial Services Corp now owns 1,335 shares of the company’s stock valued at $138,000 after buying an additional 57 shares in the last quarter. Bartlett & Co. LLC raised its position in Monsanto by 10.6% in the second quarter. Bartlett & Co. LLC now owns 1,402 shares of the company’s stock valued at $145,000 after buying an additional 134 shares in the last quarter. Quadrant Capital Group LLC raised its position in Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock valued at $184,000 after buying an additional 16 shares in the last quarter. Finally, Palladium Partners LLC acquired a new position in Monsanto during the second quarter valued at $205,000. Hedge funds and other institutional investors own 78.94% of the company’s stock.
Shares of Monsanto Co. (NYSE:MON) traded down 0.24% on Monday, reaching $101.87. 718,443 shares of the company’s stock traded hands. Monsanto Co. has a one year low of $83.73 and a one year high of $114.26. The company’s 50-day moving average price is $104.39 and its 200 day moving average price is $101.78. The firm has a market cap of $44.59 billion, a P/E ratio of 34.09 and a beta of 1.19.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.02) by $0.09. The firm had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period last year, the company earned ($0.19) EPS. On average, equities analysts forecast that Monsanto Co. will post $4.89 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be given a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 2.12%. Monsanto’s payout ratio is 71.05%.
Several research firms have weighed in on MON. S&P Equity Research reiterated a “positive” rating on shares of Monsanto in a report on Thursday, September 15th. JPMorgan Chase & Co. reissued a “hold” rating on shares of Monsanto in a research note on Thursday, June 30th. Monness Crespi & Hardt dropped their price target on Monsanto from $130.00 to $128.00 and set a “buy” rating on the stock in a research note on Monday, October 3rd. Zacks Investment Research downgraded Monsanto from a “hold” rating to a “sell” rating in a research note on Friday, July 1st. Finally, Vetr raised Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 price target on the stock in a research note on Wednesday, August 3rd. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Monsanto presently has a consensus rating of “Buy” and a consensus price target of $114.65.
In other news, EVP Steven Mizell sold 310 shares of the firm’s stock in a transaction on Monday, October 10th. The stock was sold at an average price of $103.09, for a total value of $31,957.90. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Charles S. Mcmillan purchased 3,500 shares of Monsanto stock in a transaction dated Monday, October 10th. The stock was bought at an average price of $103.23 per share, for a total transaction of $361,305.00. Following the completion of the transaction, the director now directly owns 64,009 shares in the company, valued at $6,607,649.07. The disclosure for this purchase can be found here. 0.88% of the stock is owned by company insiders.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.